AzTrials
AzTrials

Spatial NeglectEMPATHNCT05595668

Engaging Mobile Prism Adaptation Treatment at Home

A study testing Prism Adaptation - 15-degree prism goggles and Prism Adaptation - 5-degree prism goggles in people with Spatial Neglect, run by Nova Scotia Health Authority at 4 sites in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Spatial neglect is a common disorder after stroke which leads to problems with noticing or responding to information from the left side of the body or space. This condition has been linked to reduced independence in a wide range of daily life activities including eating, dressing, and mobility. Read more about this study

Who is it for?
Any age
Conditions the study is for
Spatial Neglect
What is being tested?
Prism Adaptation - 15-degree prism goggles and Prism Adaptation - 5-degree prism goggles
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
4 sitesCanada
Study dates
15 Sep 2023to Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Have experienced a right hemisphere stroke (confirmed by a clinician)
  • Experience mild to severe symptoms of neglect
  • Be willing and able to consent to participate
  • Be medically stable
  • Have self-reported normal to corrected-to-normal vision
  • Be able to point to targets presented on a computer screen
  • Live within a two-hour radius of Halifax

Who cannot join

  • Other existing neurological disorders (e.g., dementia, multiple sclerosis, epilepsy).

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Anne Sophie Champod, PhD contact

9028176871

anne.champod@acadiau.ca

Canada4 sites, 4 recruiting
  • Nova Scotia Health Early Supported Stroke Discharge Team

    Bedford, Nova Scotia, B3H 4K4

    Joy Boyce, 902-473-7361, joy.boyce@nshealth.ca

    Recruiting
  • Nova Scotia Rehabilitation and Arthritis Centre (NSRAC)

    Halifax, Nova Scotia, B2T 1L7

    Anne Sophie Champod, MD

    Anne Sophie Champod, MD

    Not yet recruiting
  • Nova Scotia Rehabilitation and Arthritis Centre

    Halifax, Nova Scotia, B3H 4K4

    Matthew Miller, 902-473-7361, MatthewD.Miller@nshealth.ca

    Recruiting
  • Valley Regional Hospital

    Kentville, Nova Scotia, B4N 5E3

    Kyla Harris, 902-698-3263, kyla.harris2@nshealth.ca

    Recruiting

Other trials in Canada

About this study

Official title: Feasibility and Effectiveness of a New Computerized Treatment Protocol for Spatial Neglect Post Stroke During Inpatient and Outpatient Rehabilitation

Spatial neglect is a common disorder after stroke which leads to problems with noticing or responding to information from the left side of the body or space. This condition has been linked to reduced independence in a wide range of daily life activities including eating, dressing, and mobility. Despite its high prevalence in stroke patients, there is currently no standard of care for spatial neglect. Prism adaptation (PA) is a promising treatment, however, there are limitations to using PA in standard clinical care as it requires daily exposure for at least two weeks, yet access to equipment and supervision is limited. To solve this problem, the investigators have developed a new game-like PA treatment (Peg-the-Mole, PTM) that can be used at home without the need for daily in person therapist set-up and supervision. In this study the investigators aim to evaluate the feasibility and effectiveness of the gamified and portable PA procedure in an inpatient and home setting, with the hypothesis that the PA procedure will improve patient's neglect symptoms.

Read the detailed description

Spatial neglect is a common debilitating cognitive syndrome after stroke which is characterized by an inability to pay attention or respond to the left side of space. Thus, individuals who face this condition often experience difficulties with mobility, reading, and self-care activities such as eating, dressing, and grooming Individuals who face this condition often experience difficulties with mobility, reading, and self-care activities such as eating, dressing, and grooming which lead to increased assistance needed from a caretaker. Although this syndrome has been linked to poor rehabilitation outcomes and reduced independence in everyday life, there is currently an unmet need for an effective and feasible intervention for the treatment of spatial neglect. The investigators have developed and validated a novel, simple, and gamified computerized prism adaptation (PA) procedure for the treatment of spatial neglect. The goal of the present study is to extend this treatment to iPad administration and to test whether the protocol is feasible and effective in a typical inpatient stroke health care setting and in the home setting. Thus, the purpose of this project is to conduct a randomized, controlled, multi-site clinical trial, comparing the PA method to a placebo control intervention for the treatment of spatial neglect. The investigators will measure short- and longer-term effectiveness in terms of impairment (i.e., does PA improve neglect symptoms over time), impact on activities of daily living (i.e., foes PA improve independence in daily activities). Feasibility will be measured by overall treatment compliance and patient feedback on usability. This novel PA procedure has the potential to improve patient recovery and quality of life after stroke due to its gamified and portable features that promote treatment accessibility and adherence. The results will help determine if the treatment can be used successfully in inpatient and outpatient settings and who is likely to benefit.

A longitudinal, double-blind, randomized controlled design will be used in the present study. Patients will be randomly assigned (with stratification related to neglect severity) to PA with the use of 15-degree rightward deviating goggles (experimental condition) or PA with the use of 5-degree deviating goggles (placebo control condition). Participants will complete 10, 15-minute training sessions over approximately two weeks. These intervention sessions will involve using a novel and game-like iPad-administered PA procedure called Peg-the-Mole (PTM). Participants will complete the intervention sessions in an inpatient setting or in their homes, depending on their predicted length of hospital stay. A hybrid model will be adopted if a patient is discharged before the intervention is complete. Outcome measures will be collected immediately before, immediately after, and one-month post-treatment and compared between conditions.

Conditions
Spatial Neglect
Being tested
Prism Adaptation - 15-degree prism goggles, Prism Adaptation - 5-degree prism goggles
Keywords
Spatial Neglect, Prism Adaptation, Rehabilitation, Stroke
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prism Adaptation - 15-degree prism gogglesBehavioural

    Patients in the experimental condition will wear prism goggles while completing an iPad-administered aiming task. The prisms will shift the patients' vision 15 degrees rightward, causing a recalibration of visuo-motor information. Prism adaptation will be carried out for ten sessions for 15 minutes a day, over the span of two weeks.

  • Prism Adaptation - 5-degree prism gogglesOther

    Also called Control condition

    5-degree goggles are worn instead of the 15-degree prism goggles, while completing the same tasks as those assigned to the 15-degree condition.

Study groups in NCT05595668
Study groupRoleWhat they receive
Prism adaptation treatmentExperimentalPrism Goggles with 15-degree rightward deviating prism lenses will be used to implement prism adaptation treatment, in addition to standard care.
Receives: Behavioral: Prism Adaptation - 15-degree prism goggles
Placebo control prism adaptation treatmentPlacebo comparatorPrism goggles with 5-degree rightward deviating prism lenses will be used to maintain the double-blind methodology.
Receives: Other: Prism Adaptation - 5-degree prism goggles

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Test of neglect severity 1

    Change in Behavioural Inattention Test - All conventional subtests (BIT-C)

    Measured: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention

  2. Test of neglect severity 2

    Change in after-effects measured by a modified proprioceptive-and-visual straight-ahead outcome task without the use of an occlusion board

    Measured: measured immediately before and immediately after each intervention session

  3. Test of neglect severity 3

    Change in Behavioural Inattention Test - Select behavioural subtests (BIT-B): Article Reading, Menu Reading, and Picture Scanning

    Measured: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention

  4. Test of neglect impact on daily activities

    Change in an Eschenbeck Standardized Activities of Daily Living task: Filling out a Form

    Measured: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention

  5. Scale of neglect impact on daily activities

    Change in Halifax Neglect Impact Scale

    Measured: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention

  6. Measure of feasibility Measure of feasibility

    Treatment compliance with the intervention schedule daily

    Measured: logged immediately following each intervention session through training logs

  7. Measure of feasibility 2

    Patient feedback exit questionnaire

    Measured: collected immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2022
  2. Study start15 Sep 2023
  3. Primary completionNov 2026 (estimated)
  4. Study completionNov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05595668
Sponsor's protocol ID
EMPATH
Acronym
EMPATH
Status last verified
Jul 2025
First submitted
14 Oct 2022
Last updated
30 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • MacPhee C, Eskes G, Mackinnon SP, Champod AS. EMPATH protocol: Randomized, double-blind trial of an Engaging and Mobile Prism Adaptation Treatment for spatial neglect in Home and rehabilitation settings. PLoS One. 2026 Aug 17;21(8):e0356055. doi: 10.1371/journal.pone.0356055. eCollection 2026.

    PubMed 42607058

Questions about this trial

What is this clinical trial studying?

A study testing Prism Adaptation - 15-degree prism goggles and Prism Adaptation - 5-degree prism goggles in people with Spatial Neglect, run by Nova Scotia Health Authority at 4 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anne Sophie Champod, PhD (9028176871, anne.champod@acadiau.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Test of neglect severity 1 (time frame: taken at baseline (immediately before the intervention), immediately after the intervention, and one month after the intervention). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05595668, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in